Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Reports of relationship changes after GLP-1–associated weight loss have prompted the label “Ozempic divorces.” The article draws on anecdotes and bariatric-surgery research, neither of which establishes that these medications increase divorce risk.
Endocrinology, Diabetes, Metabolism November 12th 2026
Healthline
Among middle-aged women taking semaglutide, menopause hormone therapy use was associated with greater weight loss in an observational conference study. Tirzepatide findings were less consistent, and the results have not undergone journal peer review.
Ambulatory Care Nursing November 12th 2026
News Medical
A secondary analysis of CARBFUNC found divergent lipid responses to a very-low-carbohydrate, high-saturated-fat diet in adults with obesity. ApoB remained largely unchanged despite higher LDL-C, while long-term cardiovascular outcomes remain unresolved.
Cardiology November 11th 2026
Verywell Health
A consumer overview describes metformin’s potential roles in weight management, ovarian syndrome symptoms, and cardiovascular outcomes, but the reported findings involve different populations and do not establish equivalent benefits across these uses.
Clinical Pharmacology November 3rd 2026
Medical News Today (MNT)
Among 39 adults who had stopped GLP-1 therapy after substantial weight loss, medically tailored meals and app-based behavioral support were associated with less four-month weight regain than usual care in a small pilot trial.
Endocrinology, Diabetes, Metabolism November 2nd 2026
Medical Xpress
Among 46 children initially at healthy weight, greater ultraprocessed food intake was associated with stronger dorsal striatal responses to appetizing food cues, which were also associated with increased adiposity measures 1 year later.
Endocrinology, Diabetes, Metabolism October 29th 2026